Enara Herrán

Chitosan coated nanostructured lipid carriers for brain delivery of proteins by intranasal administration

Oihane Gartziandia, Enara Herrán, José Luís Pedraz et al. · Colloids and Surfaces B Biointerfaces · 2015 · 186 citations

Nanoparticles, Nanomedicine, Intranasal Administration +7

Intranasal Administration of TAT-Conjugated Lipid Nanocarriers Loading GDNF for Parkinson’s Disease

Sara Hernando, Enara Herrán, Joana Figueiro‐Silva et al. · Molecular Neurobiology · 2017 · 131 citations · Full text

Nanomedicine, Neurodegenerative Diseases, Intranasal Administration +9

Intranasal Administration of Chitosan-Coated Nanostructured Lipid Carriers Loaded with GDNF Improves Behavioral and Histological Recovery in a Partial Lesion Model of Parkinson's Disease

Oihane Gartziandia, Enara Herrán, José Ángel Ruíz-Ortega et al. · Journal of Biomedical Nanotechnology · 2016 · 92 citations

Nanoparticles, Nanotherapeutics, Engineering +19

Beneficial effects of n-3 polyunsaturated fatty acids administration in a partial lesion model of Parkinson's disease: The role of glia and NRf2 regulation

Sara Hernando, Catalina Requejo, Enara Herrán et al. · Neurobiology of Disease · 2018 · 90 citations · Full text

Metabolic Syndrome, Lipid Synthesis, Beneficial Effects +9

In vivo administration of VEGF- and GDNF-releasing biodegradable polymeric microspheres in a severe lesion model of Parkinson’s disease

Enara Herrán, José Ángel Ruíz-Ortega, Asier Aristieta et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2013 · 67 citations

Regenerative Medicine, Nanomedicine, Neurodegenerative Diseases +10